AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimniv M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Nivulia Lifesciences Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimniv M 1mg/500mg Tablet

Diabex Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two drugs for adult type 2 diabetes management. They help regulate blood glucose in diabetic patients. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is vital, even with controlled blood sugar or well-being; abrupt cessation can elevate blood glucose, increasing risks of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic approach including diet, exercise, and weight management as directed by your doctor; lifestyle factors are crucial for diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and how to manage them. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects encompass altered taste, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory infections; weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment; pregnancy or breastfeeding necessitates medical consultation. Regular blood glucose monitoring, and potentially blood cell and liver function tests, are recommended by your doctor.

Uses of Glimniv M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimniv M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Glimniv M 1mg/500mg tablets should be administered with a meal.

Common Side effects of Glimniv M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimniv M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Glimniv M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Glimniv M 1mg/500mg Tablet works:

Glimniv M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimniv M 1mg/500mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glimniv M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimniv M 1mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimniv M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimniv M 1mg/500mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimniv M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimniv M 1mg/500mg Tablet :

Should you forget to take a Glimniv M 1mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimniv M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimniv M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Glimniv M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimniv M 1mg/500mg Tablets and seek immediate medical attention.
Glimniv M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimniv M 1mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Glimniv M 1mg/500mg Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glimniv M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimniv M 1mg/500mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimniv M 1mg/500mg Table...
49
MRP 60
18% off